Get started
CORCEPT THERAPEUTICS INC COM STK USD0.00001CORCEPT THERAPEUTICS INC COM STK USD0.00001CORCEPT THERAPEUTICS INC COM STK USD0.00001

CORCEPT THERAPEUTICS INC COM STK USD0.00001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0I3Q chart


Full chart

0I3Q upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.24 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
46.68
Basic EPS (TTM)
1.36 USD
Net income (FY)
‪105.50 M‬ USD
Revenue (FY)
‪482.38 M‬ USD
Shares float
‪90.20 M‬
Beta (1Y)
1.73

Employees


Employees (FY)
352
Change (1Y)
+53 +17.73%
Revenue / Employee (1Y)
‪1.37 M‬ USD
Net income / Employee (1Y)
‪299.70 K‬ USD

About Corcept Therapeutics Incorporated


Sector
Health Technology
CEO
Joseph K. Belanoff
Headquarters
Menlo Park
Website
corcept.com
Founded
1998
FIGI
BBG00JVRNF23
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0I3Q news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0I3Q is 57.82 USD — it has decreased by −2.19% in the past 24 hours. Watch CORCEPT THERAPEUTICS INC COM STK USD0.00001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CORCEPT THERAPEUTICS INC COM STK USD0.00001 stocks are traded under the ticker 0I3Q.
0I3Q stock has risen by 14.49% compared to the previous week, the month change is a 26.12% rise, over the last year CORCEPT THERAPEUTICS INC COM STK USD0.00001 has showed a 136.74% increase.
We've gathered analysts' opinions on CORCEPT THERAPEUTICS INC COM STK USD0.00001 future price: according to them, 0I3Q price has a max estimate of 80.00 USD and a min estimate of 67.00 USD. Watch 0I3Q chart and read a more detailed CORCEPT THERAPEUTICS INC COM STK USD0.00001 stock forecast: see what analysts think of CORCEPT THERAPEUTICS INC COM STK USD0.00001 and suggest that you do with its stocks.
0I3Q reached its all-time high on Nov 8, 2024 with the price of 58.70 USD, and its all-time low was 11.52 USD and was reached on Feb 25, 2019. View more price dynamics on 0I3Q chart.
See other stocks reaching their highest and lowest prices.
0I3Q stock is 4.69% volatile and has beta coefficient of 1.73. Track CORCEPT THERAPEUTICS INC COM STK USD0.00001 stock price on the chart and check out the list of the most volatile stocks — is CORCEPT THERAPEUTICS INC COM STK USD0.00001 there?
Today CORCEPT THERAPEUTICS INC COM STK USD0.00001 has the market capitalization of ‪6.19 B‬, it has increased by 19.06% over the last week.
Yes, you can track CORCEPT THERAPEUTICS INC COM STK USD0.00001 financials in yearly and quarterly reports right on TradingView.
CORCEPT THERAPEUTICS INC COM STK USD0.00001 is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
0I3Q earnings for the last quarter are 0.41 USD per share, whereas the estimation was 0.28 USD resulting in a 45.42% surprise. The estimated earnings for the next quarter are 0.38 USD per share. See more details about CORCEPT THERAPEUTICS INC COM STK USD0.00001 earnings.
CORCEPT THERAPEUTICS INC COM STK USD0.00001 revenue for the last quarter amounts to ‪182.55 M‬ USD, despite the estimated figure of ‪171.97 M‬ USD. In the next quarter, revenue is expected to reach ‪198.04 M‬ USD.
0I3Q net income for the last quarter is ‪46.69 M‬ USD, while the quarter before that showed ‪35.12 M‬ USD of net income which accounts for 32.94% change. Track more CORCEPT THERAPEUTICS INC COM STK USD0.00001 financial stats to get the full picture.
No, 0I3Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2024, the company has 352.00 employees. See our rating of the largest employees — is CORCEPT THERAPEUTICS INC COM STK USD0.00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORCEPT THERAPEUTICS INC COM STK USD0.00001 EBITDA is ‪144.81 M‬ USD, and current EBITDA margin is 22.46%. See more stats in CORCEPT THERAPEUTICS INC COM STK USD0.00001 financial statements.
Like other stocks, 0I3Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORCEPT THERAPEUTICS INC COM STK USD0.00001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CORCEPT THERAPEUTICS INC COM STK USD0.00001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CORCEPT THERAPEUTICS INC COM STK USD0.00001 stock shows the buy signal. See more of CORCEPT THERAPEUTICS INC COM STK USD0.00001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.